share_log

StockNews.com Downgrades Mettler-Toledo International (NYSE:MTD) to Buy

Defense World ·  Sep 24, 2022 02:11

Mettler-Toledo International (NYSE:MTD – Get Rating) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating in a report issued on Saturday.

Several other analysts also recently issued reports on the stock. Robert W. Baird upped their price target on shares of Mettler-Toledo International from $1,369.00 to $1,406.00 and gave the company a "neutral" rating in a report on Monday, August 1st. The Goldman Sachs Group reduced their price target on shares of Mettler-Toledo International from $1,280.00 to $1,140.00 and set a "sell" rating on the stock in a report on Thursday, July 14th. Stifel Nicolaus raised shares of Mettler-Toledo International from a "hold" rating to a "buy" rating and set a $1,500.00 price target on the stock in a report on Tuesday, September 6th. UBS Group started coverage on shares of Mettler-Toledo International in a research note on Wednesday, July 20th. They set a "neutral" rating and a $1,237.00 price objective on the stock. Finally, TheStreet downgraded shares of Mettler-Toledo International from a "b" rating to a "c+" rating in a research note on Thursday, July 28th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of "Hold" and a consensus price target of $1,338.60.

Get Mettler-Toledo International alerts:

Mettler-Toledo International Trading Down 0.3 %

Shares of MTD opened at $1,132.01 on Friday. The company has a current ratio of 1.18, a quick ratio of 0.77 and a debt-to-equity ratio of 250.82. The firm's 50-day moving average is $1,267.94 and its two-hundred day moving average is $1,269.03. Mettler-Toledo International has a twelve month low of $1,082.78 and a twelve month high of $1,714.75. The firm has a market capitalization of $25.48 billion, a P/E ratio of 31.90, a PEG ratio of 2.86 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD – Get Rating) last issued its earnings results on Friday, July 29th. The medical instruments supplier reported $9.39 earnings per share for the quarter, topping the consensus estimate of $8.78 by $0.61. Mettler-Toledo International had a net margin of 21.23% and a return on equity of 799.34%. The company had revenue of $978.39 million for the quarter, compared to analyst estimates of $951.81 million. During the same period in the prior year, the business posted $8.10 earnings per share. The firm's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, research analysts predict that Mettler-Toledo International will post 38.99 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Shawn Vadala sold 800 shares of the company's stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $1,344.06, for a total transaction of $1,075,248.00. Following the completion of the transaction, the chief financial officer now owns 4,900 shares of the company's stock, valued at $6,585,894. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Shawn Vadala sold 800 shares of the company's stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $1,344.06, for a total transaction of $1,075,248.00. Following the completion of the transaction, the chief financial officer now owns 4,900 shares of the company's stock, valued at $6,585,894. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Olivier A. Filliol sold 374 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $1,314.05, for a total transaction of $491,454.70. Following the completion of the sale, the director now directly owns 30 shares of the company's stock, valued at approximately $39,421.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,440 shares of company stock valued at $27,465,861. Insiders own 2.80% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Large investors have recently made changes to their positions in the business. Stock Yards Bank & Trust Co. grew its holdings in Mettler-Toledo International by 1.5% during the 2nd quarter. Stock Yards Bank & Trust Co. now owns 533 shares of the medical instruments supplier's stock valued at $612,000 after purchasing an additional 8 shares in the last quarter. Eaton Vance Management grew its holdings in Mettler-Toledo International by 0.6% during the 4th quarter. Eaton Vance Management now owns 1,584 shares of the medical instruments supplier's stock valued at $1,965,000 after purchasing an additional 9 shares in the last quarter. Private Trust Co. NA grew its holdings in Mettler-Toledo International by 1.2% during the 2nd quarter. Private Trust Co. NA now owns 783 shares of the medical instruments supplier's stock valued at $899,000 after purchasing an additional 9 shares in the last quarter. Main Street Financial Solutions LLC grew its holdings in Mettler-Toledo International by 2.8% during the 1st quarter. Main Street Financial Solutions LLC now owns 365 shares of the medical instruments supplier's stock valued at $501,000 after purchasing an additional 10 shares in the last quarter. Finally, Personal CFO Solutions LLC grew its holdings in Mettler-Toledo International by 1.4% during the 1st quarter. Personal CFO Solutions LLC now owns 747 shares of the medical instruments supplier's stock valued at $1,026,000 after purchasing an additional 10 shares in the last quarter. Institutional investors and hedge funds own 93.00% of the company's stock.

Mettler-Toledo International Company Profile

(Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Read More

  • Get a free copy of the StockNews.com research report on Mettler-Toledo International (MTD)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • 2 Semiconductor Stocks To Watch For Reversals
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment